Warhound Raises $200M to Clone and Gene-Edit Military Working Dogs

Key takeaways

• Warhound, a Texas-based defense startup, came out of stealth on October 22, 2026 with a $200 million seed round to build a domestic US supply of military working dogs using cloning and gene editing.
• TechCrunch reported that the round values Warhound at $1.2 billion. The company's press release does not state a valuation.
• The idea came from Colossal Biosciences CEO Ben Lamm and Anduril founder Palmer Luckey. Lamm told TechCrunch that Luckey holds no equity in Warhound and is a partner only.
• The first cloned puppies are expected to be born in early 2027, according to TechCrunch. Lamm hopes the dogs will enter service within about two years.
• Warhound has no signed customers and has not set a price per dog, according to Fortune and TechCrunch.

Warhound, a startup conceived by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, launched on October 22, 2026 with a $200 million round to clone and gene-edit military working dogs for the US military, police and emergency services. First puppies are expected in early 2027.

What happened: Warhound's military working dogs plan

The company announced its launch in a press release on PR Newswire at 19:15 ET on October 22 (23:15 UTC), datelined Dallas and Costa Mesa, California. TechCrunch and Fortune published reports within the next half hour.

The release lists In-Q-Tel, Sequoia Capital, ARK Invest, Franklin Templeton, 8VC, USIT, Bob Nelsen, Breyer Capital, CAZ Investments, Neogenesis, Builders VC and Lux Capital among the investors in the $200 million seed round. In-Q-Tel is the not-for-profit venture firm that invests on behalf of the US intelligence community.

Warhound describes a "vertically integrated" program that covers genetics, secure biobanking, cloning, training and animal care. Its chief executive is David Spirk, a US Marine Corps veteran who served as the first chief data officer of the Pentagon and of US Special Operations Command, and later as a senior counselor at Palantir Technologies, according to the release and Fortune.

Who does what

What we know

• The breeds. TechCrunch reported that the team began with Belgian Malinois and German Shepherds, two common working breeds, and stored cell lines from top-performing dogs in a biobank.
• The edits. Lamm told TechCrunch the goals include health, longevity, speed, agility and better scent detection for finding explosives. Fortune reported that the first group of dogs has been biobanked and is being edited. Lamm described Anduril's gear as "on top of the dog, not in the dog," meaning the hardware is worn, not implanted.
• The problem it targets. According to company figures cited by Fortune and TechCrunch, more than 80% of US military working dogs are bought from Europe, and fewer than half of purchased dogs are judged fit for service. Fortune reported that the US must buy and train about 200 dogs to field 100.
• The customers. Warhound is targeting the Department of Defense, military units, police forces and first responders. Fortune reported that the company is discussing a "Canine-as-a-Service" model.

In the release, Luckey said: "Man's best friend deserves man's best tech."

What we don't know yet

• Which specific genes will be edited, and how any edits will be tested for safety before dogs enter service.
• Whether the Pentagon or any police agency will buy the dogs. Fortune reported there are no signed customers.
• The price per dog, which TechCrunch said has not been set.
• Whether federal regulators will review the gene-edited animals. The company has not detailed a regulatory path.

Background

Colossal Biosciences, which Lamm leads, drew global attention in April 2025 when it announced what it called "dire wolves." Some scientists said the animals were gene-edited gray wolves rather than a revived species. Fortune reported that Lamm rejected that criticism and said it does not apply to Warhound.

Anduril, founded by Luckey, builds autonomous systems and other defense hardware for the US military. Lamm told Fortune he rejected the idea of a combined Colossal-Anduril company. The two companies are suppliers and partners to Warhound, not its owners.

What it means

Warhound is one of the first venture-backed attempts to apply commercial cloning and gene editing to animals used by the military. If it works, it could shorten a supply chain that now depends heavily on foreign breeders and loses more than half of its candidates in training, according to company figures.

The bets are still unproven. The company has money, partners and a timeline, but no contracts and no pricing. Animal welfare oversight, the reliability of edited traits, and buyers' willingness to pay for cloned dogs will decide whether the plan reaches the field. Readers can follow related defense and technology stories in our coverage of the FCC's block on devices with Chinese surveillance chips, Ukraine's strikes on Russian data centers, SpaceX's third-quarter AI revenue and Disney's $180 million Character.AI staff deal.

Sources

• PR Newswire: Warhound launches with $200 million to rebuild America's military working dog supply (company release, Oct. 22, 2026)
• TechCrunch: Warhound raises $200M to engineer war dogs and arm them with Anduril gear
• Fortune: Palmer Luckey and Ben Lamm's Warhound raises $200 million
• TechCrunch on X: Warhound announcement post